Black Diamond Therapeutics Inc (BDTX) - Financial and Strategic SWOT Analysis Review

Black Diamond Therapeutics Inc (BDTX) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Black Diamond Therapeutics Inc (Black Diamond) is a precision oncology medicine company. It discovers small molecules and tumor-agnostic therapies for the treatment of cancer. The company’s pipeline product candidates include BDTX- 4933 is designed to be a brain penetrant and highly selective and potent inhibitor of oncogenic BRAF Class I, II, III and active RAF dimers promoted by upstream oncogenic alterations; and BDTX-1535, a brain-penetrant small-molecule inhibitor for the treatment of glioblastoma, affecting the brain or spine. It is also developing its Mutation-Allostery-Pharmacology (MAP) technology platform, to identify oncogenic mutations that promote cancer. Black Diamond is headquartered in Cambridge, Massachusetts, the US.

Black Diamond Therapeutics Inc Key Recent Developments

Apr 11,2024: Black Diamond Therapeutics Announces Changes to Board of Directors
Mar 12,2024: Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Aug 11,2023: Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Jun 02,2023: Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Black Diamond Therapeutics Inc - Key Facts
Black Diamond Therapeutics Inc - Key Employees
Black Diamond Therapeutics Inc - Key Employee Biographies
Black Diamond Therapeutics Inc - Major Products and Services
Black Diamond Therapeutics Inc - History
Black Diamond Therapeutics Inc - Company Statement
Black Diamond Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Black Diamond Therapeutics Inc - Business Description
R&D Overview
Black Diamond Therapeutics Inc - Corporate Strategy
Black Diamond Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Black Diamond Therapeutics Inc - Strengths
Black Diamond Therapeutics Inc - Weaknesses
Black Diamond Therapeutics Inc - Opportunities
Black Diamond Therapeutics Inc - Threats
Black Diamond Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Black Diamond Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Black Diamond Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Black Diamond Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 11, 2024: Black Diamond Therapeutics Announces Changes to Board of Directors
Mar 12, 2024: Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Aug 11, 2023: Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Jun 02, 2023: Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference
May 09, 2023: Black Diamond Therapeutics reports first quarter 2023 financial results and provides corporate update
Apr 18, 2023: Black Diamond Therapeutics to present at the Stifel 2023 Targeted Oncology Days
Mar 09, 2023: Black Diamond Therapeutics Q4 EPS Results Exceed Expectations Driving Share Price Increase
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Black Diamond Therapeutics Inc, Key Facts
Black Diamond Therapeutics Inc, Key Employees
Black Diamond Therapeutics Inc, Key Employee Biographies
Black Diamond Therapeutics Inc, Major Products and Services
Black Diamond Therapeutics Inc, History
Black Diamond Therapeutics Inc, Other Locations
Black Diamond Therapeutics Inc, Subsidiaries
Black Diamond Therapeutics Inc, Key Competitors
Black Diamond Therapeutics Inc, Ratios based on current share price
Black Diamond Therapeutics Inc, Annual Ratios
Black Diamond Therapeutics Inc, Annual Ratios (Cont...1)
Black Diamond Therapeutics Inc, Interim Ratios
Black Diamond Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Black Diamond Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Black Diamond Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Black Diamond Therapeutics Inc, Ratio Charts
Black Diamond Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Black Diamond Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings